In particular, the gene expression changes associated with schizophrenia risk in placenta indicated EIF2 signaling pathways, inhibition of mTOR signaling, activation of the Estrogen Receptor, and Insulin secretion and receptor signaling. This evidence concerns the gene MTOR and schizophrenia.